MCG

Genetesis Announces Formal Publication of Results from the MAGNETO Trial

Retrieved on: 
Tuesday, April 2, 2024
Health, Other Health, General Health, Clinical Trials, Research, Science, Cardiology, Radiation, Ascension Michigan, Dipyridamole, Moyamoya disease, Risk, Patient, Emergency medicine, Guideline, Ischemia, MD, Publication, FACEP, ED, Medical director, MCG, Medical device

Genetesis, Inc., a leader in the field of magnetocardiography (MCG), today announced that official results from its MAGNETO trial were published in a special issue of the American Heart Journal Plus: Cardiology Research and Practice .

Key Points: 
  • Genetesis, Inc., a leader in the field of magnetocardiography (MCG), today announced that official results from its MAGNETO trial were published in a special issue of the American Heart Journal Plus: Cardiology Research and Practice .
  • The results of MAGNETO demonstrate MCG’s ability to identify myocardial ischemia in low-to-intermediate risk patients presenting to the emergency department (ED) with acute chest pain and validate MCG’s performance compared to tests that comprise the current standard of care.
  • “To the extent of my awareness, this constitutes the most extensive MCG trial conducted in the past 60 years, dating back to the inception of MCG research.
  • Additional analyses of data collected in the MAGNETO trial are also planned for publication in the same special issue where topline results have just been published.

Evolv Express® Operating at Ten Professional Baseball Stadiums on MLB Opening Day 2024

Retrieved on: 
Wednesday, March 27, 2024
Basketball, Security, Sports, Technology, General Sports, Artificial Intelligence, USA Today, Boston Red Sox, Weapon, MCG, Sporting Kansas City, Boston Bruins, Opening Day, School, Hospital, Fenway Park, American City Business Journals, Pittsburgh Pirates, Traction, PNC Park, Boston Celtics, Melbourne Cricket Ground, Sport

John Baier, Evolv’s vice president of sports, marked the occasion by stating, “Like baseball fans across the country, we celebrate Opening Day and the start of baseball in 2024.

Key Points: 
  • John Baier, Evolv’s vice president of sports, marked the occasion by stating, “Like baseball fans across the country, we celebrate Opening Day and the start of baseball in 2024.
  • To date, the company counts as customers 11 professional football teams, 10 professional soccer teams, nine professional hockey teams and seven professional basketball teams.
  • Evolv Express systems screened more than one billion people and detect an average of more than 1,000 weapons on a typical day.
  • Evolv recently received recognition from Sports Business Journal , which named Evolv Express as both “Best in Fan Experience Technology” and “Best in Sports Technology” for 2024.

Mary Washington Healthcare Experts to Speak at ACMA National Conference on Reducing Hospital Length of Stay

Retrieved on: 
Thursday, April 4, 2024
Conference, Documentation, FHIR, Management, Health, Patient, Mary Washington Hospital, MD, Length of stay, Music City Center, Hearst Communications, Nursing, ACMA, CMO, Central Time, MCG

NASHVILLE, Tenn., April 4, 2024 /PRNewswire-PRWeb/ -- MCG Health, part of the Hearst Health network and an industry leader in technology-enabled, evidence-based guidance, announces its partners and thought leaders from Mary Washington Healthcare will speak at the 2024 ACMA National Conference. The ACMA conference runs from April 19-22, 2024, at the Music City Center in downtown Nashville, Tennessee.

Key Points: 
  • "Mary Washington Healthcare's implementation of MCG Indicia for Admission Documentation technology has enhanced our new care coordination model."
  • This resulted in Mary Washington Healthcare moving from the bottom 10 percent for length of stay to the top 10 percent.
  • Reducing excess days allowed Mary Washington Healthcare to optimize the use of existing resources ultimately decreasing their nursing premium costs.
  • For more information on the 2024 ACMA National Conference in Nashville, Tennessee, visit the conference website here: https://events.acmaweb.org/website/55550/home/

Luckie & Company Acquires Marbury Creative Group

Retrieved on: 
Tuesday, April 2, 2024
Growth, Partnership, Alimera Sciences, Acquisition, Food, Senior, Spice World, Owens & Minor, Marketing, Advertising, MCG, Sales

ATLANTA and BIRMINGHAM, Ala., April 2, 2024 /PRNewswire/ -- Luckie & Company announces  the acquisition of Marbury Creative Group (MCG), an Atlanta-based creative marketing agency recognized for its work in the pharmaceutical, food & beverage, and hospitality industries.

Key Points: 
  • ATLANTA and BIRMINGHAM, Ala., April 2, 2024 /PRNewswire/ -- Luckie & Company announces  the acquisition of Marbury Creative Group (MCG), an Atlanta-based creative marketing agency recognized for its work in the pharmaceutical, food & beverage, and hospitality industries.
  • Marketing and advertising agency, Luckie & Company, expands with acquisition of Marbury Creative Group.
  • The acquisition brings Luckie expansion in critical areas, including content, search engine marketing, media strategy & planning, plus a seasoned team focused on creative, strategy, and media.
  • Marbury will be an Executive Creative Director at Luckie.

ChromaCode Announces Partnership with Department of Pathology, Medical College of Georgia on rapid testing for critical biomarkers in Non-Small Cell Lung Cancer

Retrieved on: 
Wednesday, March 20, 2024
Genomics, NSCLC, Professor, Partnership, Medical college, Patient, RNA, DNA, CBO, NCCN, Cancer, National Comprehensive Cancer Network, Diagnosis, Deletion, MCG, Medical College of Georgia, Medical imaging

CARLSBAD, Calif., March 20, 2024 /PRNewswire/ -- ChromaCode, Inc., a pioneering genomics multiplexing platform company developing accessible and affordable laboratory-based solutions, today announced a partnership with Department of Pathology, Medical College of Georgia, to test the analytical and clinical performance of ChromaCode's HDPCR non-small cell lung cancer (NSCLC) biomarker assay.

Key Points: 
  • CARLSBAD, Calif., March 20, 2024 /PRNewswire/ -- ChromaCode, Inc., a pioneering genomics multiplexing platform company developing accessible and affordable laboratory-based solutions, today announced a partnership with Department of Pathology, Medical College of Georgia, to test the analytical and clinical performance of ChromaCode's HDPCR non-small cell lung cancer (NSCLC) biomarker assay.
  • Recently published research in the journal Diagnostics ( https://doi.org/10.3390/diagnostics13213299 ) shows the remarkable sensitivity of the NSCLC assay, even with minimal input material.
  • Department of Pathology, Medical College of Georgia will continue the validation process to establish the analytical and clinical performance of the NSCLC kit.
  • Given our shared vision, we look ahead to a fruitful partnership in the development of our NSCLC test," said Padma Sundar, CBO of ChromaCode.

MCG Recognizes CareSource with 2023 Richard L. Doyle Award for Transforming Inpatient Authorization Workflows

Retrieved on: 
Tuesday, March 12, 2024
Organization, Innovation, Citation, Collaborative Care, Medicine, Communication, Health, Hospital, MCO, Cleveland Clinic, Hearst Communications, CareSource, EHR, Collection, MCG

DAYTON, Ohio, March 12, 2024 /PRNewswire-PRWeb/ -- MCG Health, part of the Hearst Health network and an industry leader in technology-enabled, evidence-based guidance, has named CareSource a recipient of its 2023 Richard L. Doyle Award for Innovation and Leadership in Healthcare. The nonprofit managed care organization (MCO) was recognized for successfully collaborating with hospitals to transform the inpatient authorization process.

Key Points: 
  • The nonprofit managed care organization (MCO) was recognized for successfully collaborating with hospitals to transform the inpatient authorization process.
  • MCG Health President and CEO, Jon Shreve said, "We congratulate CareSource on receiving the Doyle Award as it reflects their collaborative nature and technological determination.
  • In addition to MCG Cite for Collaborative Care, CareSource continues to drive provider adoption through its provider portal that leverages MCG Cite AutoAuth technology.
  • CareSource processes 73% of eligible authorization types through its provider portal; because of MCG Cite AutoAuth technology, CareSource can respond to 20-30% of a provider's requests during the provider's initial interaction with the CareSource Portal.

Melbourne Cricket Club Takes Evolv Technology Down Under

Retrieved on: 
Wednesday, March 6, 2024
Technology, General Sports, Sports, Security, Weapon, Hospital, Melbourne Cricket Club, MLS, AI, NBA, Club, NHL, Manchester Arena, MCG, Taylor Swift, Work, Major League Baseball, Melbourne Cricket Ground, Sport, School, SoFi Stadium, MCC, NFL, Environment, Partnership, Nightclub

Evolv Technology (NASDAQ: EVLV), the leading security technology company pioneering AI-based screening to create safer experiences, today announced its partnership with Melbourne Cricket Club (MCC), the largest – and one of the oldest - sports clubs in Australia.

Key Points: 
  • Evolv Technology (NASDAQ: EVLV), the leading security technology company pioneering AI-based screening to create safer experiences, today announced its partnership with Melbourne Cricket Club (MCC), the largest – and one of the oldest - sports clubs in Australia.
  • Managed by Melbourne Cricket Club, Melbourne Cricket Ground is a sports stadium in Yarra Park, Melbourne, Victoria.
  • Melbourne Cricket Club was introduced to Evolv by Convergint, which supplies Melbourne Cricket Ground with its other security technology.
  • “We were looking for a more efficient entry experience for guests coming to the Melbourne Cricket Ground,” said Rey Sumaru, general manager of IT & innovation for the Melbourne Cricket Club.

Mission Critical Group Acquires Point Eight Power

Retrieved on: 
Wednesday, March 6, 2024
Acquisition, Economic development, MCG, MCFI, Growth, JTS, Employment, Partnership, Management

SPICEWOOD, Texas, March 6, 2024 /PRNewswire/ -- Mission Critical Group (MCG), a power and electrical solutions company with application, manufacturing and services capabilities for critical power customers, achieves a significant milestone with the acquisition of Point Eight Power , a Louisiana-based manufacturer of high-quality, reliable switchgear and power control building solutions with production facilities in Belle Chasse, Louisiana, and Bay St. Louis, Mississippi.

Key Points: 
  • SPICEWOOD, Texas, March 6, 2024 /PRNewswire/ -- Mission Critical Group (MCG), a power and electrical solutions company with application, manufacturing and services capabilities for critical power customers, achieves a significant milestone with the acquisition of Point Eight Power , a Louisiana-based manufacturer of high-quality, reliable switchgear and power control building solutions with production facilities in Belle Chasse, Louisiana, and Bay St. Louis, Mississippi.
  • With the addition of Point Eight Power, MCG takes another step in its mission to become a premier solution provider for customers with power-intensive applications.
  • "We're thrilled to welcome Point Eight Power to MCG," stated Jeff Drees, CEO of Mission Critical Group.
  • Point Eight Power joins a growing roster of other industry-leading experts within MCG, including Mission Critical Facilities International (MCFI) , a systems integrator that delivers power solutions, modular data centers, and microgrids, and JTS , a manufacturer of generator/electrical equipment enclosures and modular power systems.

MCG Experts to Speak at HIMSS 2024 on Prior Auth Automation and CMS Final Rule Compliance

Retrieved on: 
Tuesday, March 5, 2024
Data science, Hospital, Artificial intelligence, CMS, Real, HIMSS, MCG, Interoperability, Part, Health, Product management, Learning, Conference, Medicare, Hearst Communications, Associate, Patient, Automation, Workflow

ORLANDO, Fla., March 5, 2024 /PRNewswire-PRWeb/ -- MCG Health, part of the Hearst Health network and an industry leader in technology-enabled evidence-based guidance, will host two presentations at the HIMSS Global Health Conference & Exhibition (March 11-15, 2024) in Orlando, Florida. These sessions will focus on MCG's successful efforts in implementing the nation's first, scalable prior authorization automation workflow between health plans and hospitals. MCG experts will also discuss how this new technology can support compliance efforts with the Interoperability and Prior Authorization Final Rule (CMS-0057-F) which was announced by the Centers for Medicare & Medicaid Services (CMS) on January 17, 2024.

Key Points: 
  • These sessions will focus on MCG's successful efforts in implementing the nation's first, scalable prior authorization automation workflow between health plans and hospitals.
  • MCG experts will also discuss how this new technology can support compliance efforts with the Interoperability and Prior Authorization Final Rule (CMS-0057-F) which was announced by the Centers for Medicare & Medicaid Services (CMS) on January 17, 2024.
  • Their presentation, "AI & Interoperability: Optimizing Prior Authorization Automation", will take place in the HIMSS Interoperability Theater on Tuesday, March 12, 2024, from 11:15-11:35 AM ET.
  • With the release of the CMS Interoperability and Prior Authorization Final Rule, MCG is well-prepared to expand this optimized workflow, promote payer-provider collaboration, and help patients receive the right care at the right time."

MCG Releases 28th Edition of Guidelines with New Support for the 2024 Medicare Advantage Final Rule

Retrieved on: 
Tuesday, February 27, 2024
Language, Hospital, Addiction medicine, CMS, MCG, Health, Transport, Medicare Advantage, Citation, Data, ASAM, Ambulatory care, Society, Medicare, Hearst Communications, Health insurance

SEATTLE, Feb. 27, 2024 /PRNewswire-PRWeb/ -- MCG Health, part of the Hearst Health network and an industry leader in technology-enabled evidence-based guidance, announces the release of its 28th edition of the MCG care guidelines. Many new changes to the industry-leading guidelines were made to help payers and providers support compliance with the 2024 Medicare Advantage and Part D Final Rule (CMS-4201-F) which was announced by the Centers for Medicare & Medicaid Services (CMS) in April 2023.

Key Points: 
  • Many new changes to the industry-leading guidelines were made to help payers and providers support compliance with the 2024 Medicare Advantage and Part D Final Rule (CMS-4201-F) which was announced by the Centers for Medicare & Medicaid Services (CMS) in April 2023.
  • - Jon Shreve, President & CEO, MCG Health
    MCG care guidelines are among the most widely used clinical guidelines in the healthcare industry.
  • The updates were designed to help payers and providers support compliance with the 2024 Medicare Advantage and Part D Final Rule (CMS-4201-F).
  • In addition, MCG will hold several educational sessions related to the 28th edition at their annual Client Forum in Phoenix, Arizona (April 22-24).